Q4 2024 EPS Estimates for Teleflex Incorporated Raised by Analyst (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX) – Stock analysts at Zacks Research increased their Q4 2024 earnings per share (EPS) estimates for shares of Teleflex in a report issued on Wednesday, September 25th. Zacks Research analyst R. Department now forecasts that the medical technology company will post earnings per share of $3.88 for the quarter, up from their prior forecast of $3.87. The consensus estimate for Teleflex’s current full-year earnings is $13.97 per share. Zacks Research also issued estimates for Teleflex’s Q1 2025 earnings at $3.47 EPS, Q3 2025 earnings at $3.90 EPS, Q4 2025 earnings at $4.25 EPS and Q1 2026 earnings at $3.98 EPS.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The business had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. During the same quarter in the previous year, the firm posted $3.41 EPS. The firm’s revenue was up .9% on a year-over-year basis.

Several other equities research analysts have also recently issued reports on the stock. Stephens boosted their price objective on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. Royal Bank of Canada upped their price target on Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. Truist Financial increased their price objective on shares of Teleflex from $240.00 to $247.00 and gave the company a “hold” rating in a research report on Monday, August 5th. Finally, Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $265.57.

Teleflex Trading Up 0.8 %

TFX stock opened at $246.83 on Friday. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.36. Teleflex has a twelve month low of $177.63 and a twelve month high of $257.85. The stock has a market capitalization of $11.63 billion, a price-to-earnings ratio of 39.62, a price-to-earnings-growth ratio of 2.23 and a beta of 1.16. The firm’s fifty day simple moving average is $236.98 and its two-hundred day simple moving average is $221.08.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.55%. The ex-dividend date was Thursday, August 15th. Teleflex’s payout ratio is presently 21.83%.

Insider Activity

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now directly owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 1.43% of the company’s stock.

Hedge Funds Weigh In On Teleflex

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Riverview Trust Co acquired a new position in shares of Teleflex in the 1st quarter valued at $31,000. Pineridge Advisors LLC purchased a new stake in shares of Teleflex in the fourth quarter valued at about $35,000. Canada Pension Plan Investment Board acquired a new stake in shares of Teleflex during the second quarter worth about $42,000. Versant Capital Management Inc grew its holdings in shares of Teleflex by 20,700.0% during the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after buying an additional 207 shares during the last quarter. Finally, Blue Trust Inc. increased its position in Teleflex by 78.2% in the 2nd quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock valued at $48,000 after acquiring an additional 93 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.